文档介绍：2010 ASCO 肺癌部分论文摘要中英文对照汇编解读
主编: 张力王孟昭肖毅
编译: 王汉萍任冠军陈佳琦邓庆媛
中国抗癌协会和北京协和医院肺癌诊疗中心
目录
7000 A randomized paring endosonography followed by surgical staging versus surgical
mediastinal staging alone in non-small cell lung cancer: The ASTER study................................... 1
7000 译文比较非小细胞肺癌超声内镜分期后加做手术分期和单独手术分期的随机临床试
验:ASTER研究.............................................................................................................................. 2
7004 A phase III, intergroup, randomized, double-blind, chemoprevention trial of selenium (Se)
supplementation in resected stage I non-small cell lung cancer (NSCLC) ....................................... 3
7004 译文已经切除的I期非小细胞肺癌的III期,intergroup,随机,双盲,硒(Se)补充化
学预防临床试验............................................................................................................................... 4
7007 A randomized, open-label, phase III trial of NOV-002 bination with paclitaxel (P) and
carboplatin (C) versus paclitaxel and carboplatin alone for the treatment of advanced
non-small cell lung cancer (NSCLC). ............................................................................................... 5
7007 译文 NOV-002 联合紫杉醇(P)/卡铂(C)vs紫杉醇和卡铂治疗NSCLC的随机、开放
的III期临床试验............................................................................................................................... 6
7008 Impact of KRAS mutations on adjuvant carboplatin/paclitaxel in surgically resected stage IB
NSCLC: CALGB 9633. .................................................................................................................... 7
7008 译文 KRAS突变对于手术切除的IB期NSCLC患者行铂+紫杉醇方案化疗敏感性的影
响:CALGB 9633 ............................................................................................................................ 9
7009 Initial results of LC-MAP: An institutional program to routinely profile tumor specimens for
the presence of mutations in targetable pathways in all patients with lu